With skin cancer on the rise across the UK, Boots is expanding dermatology training for its in-store pharmacists. Matt Nixson ...

Small-cell lung cancer (SCLC) is one of the most lethal cancers, with patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) experiencing a median survival of just 12 months after ...

This seminar provides an overview of advances in the screening, diagnosis, and treatment of non-small-cell lung cancer and small-cell lung cancer, with a particular focus on targeted therapies and ...

The cancer cells of some men feature a striking mutation: their Y chromosome is missing altogether. Now, tantalizing research suggests that this mutation can spread ‘contagiously’ from tumour ...

"Pinpointing factors that allow cancer cells to survive during the dormancy phase, such as PIK3C3, would guide emerging clinical trials that investigate therapeutic opportunities for breast-cancer ...

A study initiated by a University of Arizona Comprehensive Cancer Center physician-scientist defined for the first time how loss of the Y chromosome in male immune cells negatively affects immune ...

More information: Hua Bao et al, Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics, Nature Medicine (2025). DOI: 10.1038/s41591-025-03735-2 Journal ...

Glioblastoma (GBM) is an aggressive and common brain cancer in adults with average life ... of Medicine have developed a dual-target CAR-T cell therapy that has slowed GBM tumor growth in nearly ...

Cancer patients given experimental treatment that programmes the body to attack rogue cells live 40 per cent longer, major research shows. Chimeric antigen receptor (CAR) T-cell therapy is a form ...